Lastest Insider Transactions Of Turning Point Therapeutics, Inc. ( TPTX )
SymbolCompany NameInsider NameTitleDateTransationSharePriceAmountFile Date
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectior2020-03-26Sell11,50046.03529,3722020-03-27 18:27:15
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectior2020-03-23Sell31,79243.111,370,4512020-03-25 18:47:02
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectior2020-03-10Sell44,00040.841,796,8432020-03-12 20:40:54
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectior2020-02-24Sell21,00052.161,095,4222020-02-26 20:20:33
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectior2019-06-27Option Exercise109,1644.98543,4062020-02-26 20:18:04
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectior2020-02-10Sell55,50064.033,553,7442020-02-12 19:31:10
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific Officer2020-01-27Sell21,00058.251,223,2842020-01-29 19:37:28
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific Officer2020-01-15Sell11,50053.12610,8532020-01-17 17:10:06
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific Officer2020-01-10Sell55,50054.703,036,0462020-01-14 19:17:08
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific Officer2019-12-18Sell48,50060.922,954,5772019-12-20 18:29:09
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific Officer2019-12-13Sell41,50058.952,446,6202019-12-17 21:09:49
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific Officer2019-12-10Sell34,50053.881,858,7092019-12-12 19:54:41
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific Officer2019-12-05Sell118,50051.776,134,7532019-12-09 20:44:05
TPTXTurning Point Therapeutics, Inc.GLAXOSMITHKLINE PLCDirectior2019-09-10Buy177,77745.007,999,9652019-09-12 16:18:46
TPTXTurning Point Therapeutics, Inc.George SimeonDirectior2019-09-10Buy177,77745.007,999,9652019-09-11 18:42:16
TPTXTurning Point Therapeutics, Inc.Larson YiEVP & Chief Financial Officer2019-09-10Buy2,22245.0099,9902019-09-11 16:16:36
TPTXTurning Point Therapeutics, Inc.Countouriotis AthenaPresident & CEO2019-09-10Buy10,00045.00450,0002019-09-11 16:15:00
TPTXTurning Point Therapeutics, Inc.Cormorant Asset Management, LP 10% Owner2019-05-14Option Exercise23,2682.1951,0622019-05-16 16:15:25
TPTXTurning Point Therapeutics, Inc.Cormorant Asset Management, LP 10% Owner2019-04-22Buy400,00018.007,200,0002019-04-25 16:08:11
TPTXTurning Point Therapeutics, Inc.GLAXOSMITHKLINE PLCDirectior 10% Owner2019-04-22Buy325,00018.005,850,0002019-04-24 19:28:07
TPTXTurning Point Therapeutics, Inc.ORBIMED ADVISORS LLCDirectior2019-04-22Buy360,00018.006,480,0002019-04-24 18:16:20
TPTXTurning Point Therapeutics, Inc.Lu HongboDirectior2019-04-22Buy60,00018.001,080,0002019-04-24 18:11:50
TPTXTurning Point Therapeutics, Inc.GORDON CARL LDirectior2019-04-22Buy360,00018.006,480,0002019-04-24 18:07:46
TPTXTurning Point Therapeutics, Inc.George SimeonDirectior2019-04-22Buy325,00018.005,850,0002019-04-24 18:04:19
TPTXTurning Point Therapeutics, Inc.Baker Brian LeeVP of Finance and Admin.2019-04-22Buy2,80018.0050,4002019-04-24 18:00:12
TPTXTurning Point Therapeutics, Inc.Countouriotis AthenaPresident & CEO2019-04-22Buy12,00018.00216,0002019-04-24 17:55:48